Veraxa Biotech Holding AG (VRXA) Total Current Liabilities (2024 - 2025)

Veraxa Biotech Holding AG (VRXA) has 2 years of Total Current Liabilities data on file, last reported at $8.3 million in Q4 2025.

• On a quarterly basis, Total Current Liabilities rose 184.71% year-over-year to $8.3 million in Q4 2025; TTM through Dec 2025 was $8.3 million, a 184.71% increase from a year earlier, with the FY2025 full-year figure at $8.3 million, up 184.71% from the prior year.
• Total Current Liabilities for Q4 2025 stood at $8.3 million, up from $2.9 million in the prior quarter.
• Over the last five years, Total Current Liabilities for VRXA reached as high as $8.3 million in Q4 2025 and fell as low as $2.9 million in Q4 2024.